Vimarsana
Biggest News Aggregation in the World

Epetraborole Clinical Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Epetraborole Clinical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Epetraborole Clinical Development Today - Breaking & Trending Today

AN2 Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates - Vimarsana News

AN2 Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates

Published: August 11, 2022

11.08.2022 - Enrolling U.S. Patients in the EBO-301 Pivotal Phase 2/3 Trial of Epetraborole in Treatment-Refractory MAC Lung Disease; Topline Results from Phase 2 Part of Trial Expected in Mid-2023Completed Enrollment in Phase 1 PK/Safety Study of Epetraborole ...

Source: wallstreet-online.de
Related Topics:
Maggie FitzpatrickCompany ContactsCompany Board Of DirectorsExchange CommissionDevelopment Rd ExpensesEpetraborole Clinical DevelopmentTherapeutics IncDevices AgencySecond QuarterRecent Business UpdatesPivotal PhaseGlobal Chief Communications OfficerJapanese PharmaceuticalMedical Devices AgencyPrivate Securities Litigation Reform ActChief Financial OfficerAnne Bowdidge Investor
AN2 Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates - Vimarsana News

AN2 Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates

Published: May 10, 2022

10.05.2022 - On Track for Several Milestones in 2022, and Supported by Strong Balance Sheet from Upsized Initial Public Offering Continued Progress Advancing Epetraborole Clinical Program with Enrollment for Pivotal Phase 2/3 Trial in Treatment-Refractory MAC ...

Source: wallstreet-online.de
Related Topics:
Mel SpigelmanMaggie FitzpatrickAnne BowdidgeCompany ContactsCompany Investigational New DrugCompany Board Of DirectorsDrug AdministrationExchange CommissionDevelopment Rd ExpensesEpetraborole Clinical DevelopmentTherapeutics IncGlobal AllianceTb Drug DevelopmentFirst QuarterRecent Business UpdatesThrough Upsized Initial PublicFast TrackOrphan DrugInvestigational New DrugQualified Infectious Disease ProductWorking GroupGlobal Chief Communications OfficerPrivate Securities Litigation Reform ActMonths Ended March